Skyline Ventures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Inactive

  • Professionals
  • 4

Professionals

  • Investments
  • 103

  • Portfolio
  • 1

  • Exits
  • 62

Exits

Skyline Ventures General Information

Company Description

Founded in 1997, Skyline Ventures is a venture capital investment firm headquartered in Palo Alto, California. The firm prefers to invest in companies based in the United States and operating in small molecule, protein therapeutics, medical devices; diagnostics, and technologies that facilitate in drug discovery and life science research sectors.

Business Details

Year Founded
1997
Investor Status
Not Making New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Corporate Office
  • 525 University Avenue
  • Suite 1350
  • Palo Alto, CA 94301
  • United States
+1 (650) 000-0000

Skyline Ventures Investments (103)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
POVISON 08-Nov-2021 Early Stage VC 000 Home Furnishings Generating Revenue
Mediterráneo Servicios de Gestión Integral 29-Oct-2018 0000000000 Buildings and Property Profitable
Sutro Biopharma 26-Jul-2018 00000 00000 000.00 Drug Delivery Generating Revenue/Not Profitable 0000 0000 00.0
Dicerna Pharmaceuticals 11-Apr-2017 0000 0000 Pharmaceuticals Generating Revenue 0000000 0000000 00.0
SI-BONE 15-Apr-2015 00000 00000 0000 Diagnostic Equipment Generating Revenue/Not Profitable 00000 000000
Collegium Pharmaceutical 05-Mar-2015 00000 00000 0000 Pharmaceuticals Generating Revenue/Not Profitable 0000 000000 00
Advion 25-Jun-2014 00 000000000 00.00 Electronic Equipment and Instruments Generating Revenue 0000 000000 00
Proteon Therapeutics 28-May-2014 00000 00000 000.00 Pharmaceuticals Generating Revenue 00000 0000 00.0
SI-BONE 28-Apr-2014 Later Stage VC 000.00 Diagnostic Equipment Generating Revenue/Not Profitable 00000 000000
Sutro Biopharma 11-Dec-2013 Later Stage VC 0000 Drug Delivery Generating Revenue/Not Profitable 0000 0000 00.0
You’re viewing 10 of 103 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Skyline Ventures Exits (62)

Company Name Exit Date Exit Type Exit Size
Mediterráneo Servicios de Gestión Integral 19-Jan-2023 Buyout/LBO
Proteon Therapeutics 09-Jan-2020 000000000000000000 000.00
SI-BONE 17-Oct-2018 000 00000
Sutro Biopharma 27-Sep-2018 000 0000
Talphera 23-Apr-2018 000000000 00000000
Collegium Pharmaceutical 13-Apr-2018 000000000 00000000
Dicerna Pharmaceuticals 31-Mar-2018 000000000 00000000
Genocea Biosciences 31-Mar-2018 000000000 00000000
Eurofins DiscoverX Products 05-Sep-2017 Merger/Acquisition
Concert Pharmaceuticals 31-Jan-2017 Secondary Transaction - Open Market
You’re viewing 10 of 62 exits. Get the full list »

Skyline Ventures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Skyline Ventures‘s full profile, request access.

Request a free trial

Skyline Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Skyline Ventures Management, Team & Partners (11)

Name Title Deals Funds Boards Office
Kerry Kenny Chief Financial Officer Palo Alto, CA
John Freund MD Founder & Managing Director 00 0 0 Palo Alto, CA
Yasunori Kaneko MD Managing Director 0 0 0 Palo Alto, CA
Eric Gordon Ph.D Partner 0 0 Palo Alto, CA
You’re viewing 4 of 11 team members. Get the full list »

Skyline Ventures Co-Investors (1)

Name With Exits Lead Partner Series Industry
Skyline Ventures (China) 0 Series chart Industry bar
To view Skyline Ventures’s complete co-investors history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »